Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

117 recalls, newest first

Class II · Moderate risk

Similasan

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

Ongoing Sterility / contamination Thea Pharma, Inc. NDC 59262-700-11 D-0501-2026
Class II · Moderate risk

iVIZIA

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

Ongoing Sterility / contamination Thea Pharma, Inc. NDC 82584-700-11 D-0500-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-41 D-0518-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-42 D-0517-2026
Class II · Moderate risk

GenTeal Tears

Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.

Ongoing Sterility / contamination Alcon Research LLC D-0492-2026
Class II · Moderate risk

Systane

Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.

Ongoing Sterility / contamination Alcon Research LLC NDC 0065-0474-01 D-0491-2026
Class II · Moderate risk

Delflex

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Ongoing Sterility / contamination Fresenius Medical Care Holdings, Inc. D-0513-2026
Class II · Moderate risk

Delflex

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Ongoing Sterility / contamination Fresenius Medical Care Holdings, Inc. D-0512-2026
Class II · Moderate risk

Vancomycin HCL

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5082-01 D-0442-2026
Class II · Moderate risk

Vancomycin HCI

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5085-01 D-0441-2026
Class II · Moderate risk

Vancomycin HCI

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5083-01 D-0440-2026
Class II · Moderate risk

norepinephrine Bitartrate

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5027-02 D-0439-2026

Recalls by year